Abstract: A blood reinfusion system for processing autologous blood for reinfusion into a patient. The system includes a suction container adapted to receive a mixture of autologous blood and impurities and extract the impurities from the mixture, a blood filter assembly adapted to further extract the impurities from the mixture, whereby whole purified autologous blood is obtained, and a blood transfer bag adapted to receive the whole purified autologous blood from the blood filter assembly.

Abstract: Described are effervescent dissolvable solid structures comprising effervescent agglomerated particles which enhance the consumer experience and can improve dissolution of the structure. Also described are processes for the Dissolvable Solid Structure comprising effervescent agglomerated particles. Also described are methods for making the effervescent agglomerated particle.

Abstract: A compound having the structures: or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein; R selected from the group consisting of H, C1-C6 alkyl, C1-C6 alkoxy and —(CH2)m—W, where W is C3-C8 cycloalkyl, bicycloalkyl, bridged bicycloalkyl, phenyl, 5- or 6-membered heteroaryl or heterocyclic containing one, two or three heteroatoms selected from the group consisting of N, S and O atoms; wherein each of said alkyl, cycloalkyl, alkoxy, heterocyclic, phenyl, naphthyl or heteroaryl may be unsubstituted or substituted by phenyl, halo, cyano, deuterium, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, —SO2—R?, —CONR?R?, NR?COR?, —NR?CONR?R?, —NR?CO2R?, —(CH2)n—SO2—R?, —NHSO2—R?, —NR?SO2—R?, —SO2NR?R?, NR?R? or SR? where R? and R? are independently H, C1-C6 alkyl or C3-C8 cycloalkyl; R1 selected from the group consisting of phenyl, naphthyl, 5- or 6-membered heteroaryl or heterocyclic containing one, two, three or four heteroatoms se

Abstract: A method for processing autologous blood for reinfusion into a patient. The method includes the step of providing a blood reinfusion system adapted to isolate and extract impurities mixed with autologous blood aspirated from an incision site of the patient for reinfusion into the subject.

Abstract: A detergent product containing one or more active agents is provided.

Abstract: The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing oxidative stress, for example in patients with type 1 or type 2 diabetes, as well as to the use of such SGLT-2 inhibitors in treatment and/or prevention of cardiovascular diseases in patients, for example type 1 or type 2 diabetes patients. The present invention further relates to certain SGLT-2 inhibitors for treating and/or preventing a metabolic disorder and preventing, reducing the risk of or delaying the occurrence of a cardiovascular event in patients, for example patients with type 1 or type 2 diabetes.

Abstract: An apparatus for demonstrating the use of a medical device includes a body adapted for receiving the medical device. The body includes at least a portion adapted for viewing the medical device when positioned in the body. A cover is provided for selectively covering the portion of the body adapted for viewing the medical device. A kit and related methods are also disclosed.

Abstract: A face shield of a face mask has two or more openings for attachment of air filters (e.g., COVID-19, T70 or T90 air filters). The two or more openings face towards the ground being substantially perpendicular to the nose and the lip of the face. A nose bridge attaches to a support fame and having a span from a first side of the nose over a top and to a second side of the nose. The nose bridge and connected portions of the support frame fully expose a front facing portion of the nose of the face.

Abstract: A process for preparing frozen particles having an average diameter of from 1 to 10 mm and comprising from 1 to 50 wt % of a frozen aqueous core and from 50 to 99 wt % of a fat-based shell is provided, the process comprising: providing a dispensing device having an inner nozzle and an outer nozzle which surrounds the inner nozzle; supplying an aqueous mix to the inner nozzle and a fat-based mix to the outer nozzle, thereby forming particles with a water-continuous core and a fat-continuous shell, and then dropping the particles into a refrigerant.

Abstract: A method for producing an edible composite of gas hydrate and ice is provided, the method comprising the steps of contacting an aqueous solution with carbon dioxide or nitrous oxide at a sufficiently high pressure to form a gas hydrate, but at a temperature preventing this; and then reducing the temperature of the solution to form the gas hydrate and ice; characterized in that the aqueous solution contains from 0.0001 to 2 wt % of an ice structuring protein. Frozen confections containing gas hydrates and methods for producing them are also provided.

Abstract: The invention relates to process for the manufacture of an frozen aerated confectionary with an overrun of at least 15 vol. % and wherein the number average length of the ice crystals is at most 100 ????, comprising the following steps: a) providing a frozen aerated confectionary with an overrun of at least 15 vol. % and wherein the number average length of the ice crystals is at most 100 ???? comprising 40 to 85 wt. % of water; 0.1 to 30 wt. % of fat; 5 to 45 wt % freezing point depressant and bulk filler; and 0.1 to 7% protein d) providing an ingredient having a Trouton ratio of at least 75, as measured in a 0.2 wt. % solution of said ingredient in water as measured at 20 degrees Celsius; wherein the ingredient is provided in an amount of 0.001 to 10 wt. %, based on the weight of the final composition; b) mixing said frozen confectionary provided at step ‘a’ with the ingredient provided at step ‘b’ to provide a frozen aerated confectionary according to the invention.

Abstract: A granulated phosphate composition that provides sufficient nutritional value as well as enhanced pelleting benefits, such as abrasiveness and lubricity, compared to other granulated phosphate feed products. The granulated phosphate composition includes a phosphate source, such as monocalcium phosphate, mono-dicalcium phosphate, or dicalcium phosphate, and one or more additives such as lubricity and abrasivity additives. The lubricity additive can include a sodium additive that lubricates the die during a feed milling or pelleting process. The abrasivity additive can include silica or sand that scours the die during the pelleting process. The increased lubricity and abrasivity attributes of the composition benefits die throughput and efficiency in the pelleting process, without compromising nutritional value in the final feed product.

Abstract: An attachable weight assembly having separable sections for attachment to a pole used in exercising. The weight assembly includes a elongated main body having a first end and a second end and a bore running through the first end, second end and elongated main body. The bore is sized to fit over a shaft. The first and second ends each have a storage area for secure storage of a molded weight. The elongated main body is separable into at least two main body sections. The main body sections are attached together using an attachment mechanism. A user attaches the weight assembly to the shaft for use during exercise.

Abstract: A method for producing an edible composite of gas hydrate and ice is provided, the method comprising the steps of contacting an aqueous solution with carbon dioxide or nitrous oxide at a sufficiently high pressure to form a gas hydrate, but at a temperature preventing this; and then reducing the temperature of the solution to form the gas hydrate and ice; characterized in that the aqueous solution contains from 0.0001 to 2 wt % of an ice structuring protein. Frozen confections containing gas hydrates and methods for producing them are also provided.

Abstract: A granulated phosphate composition that provides sufficient nutritional value as well as enhanced pelleting benefits, such as abrasiveness and lubricity, compared to other granulated phosphate feed products. The granulated phosphate composition includes a phosphate source, such as monocalcium phosphate, mono-dicalcium phosphate, or dicalcium phosphate, and one or more additives such as lubricity and abrasivity additives. The lubricity additive can include a sodium additive that lubricates the die during a feed milling or pelleting process. The abrasivity additive can include silica or sand that scours the die during the pelleting process. The increased lubricity and abrasivity attributes of the composition benefits die throughput and efficiency in the pelleting process, without compromising nutritional value in the final feed product.

Abstract: A method for producing an edible composite of gas hydrate and ice is provided, the method comprising the steps of contacting an aqueous solution with carbon dioxide or nitrous oxide at a sufficiently high pressure to form a gas hydrate, but at a temperature preventing this; and then reducing the temperature of the solution to form the gas hydrate and ice; characterized in that the aqueous solution contains from 0.01 to 5 wt % of an aerating agent. Frozen confections containing gas hydrates and methods for producing them are also provided.

Abstract: A granulated monocalcium phosphate composition that provides sufficient nutritional value as well as enhanced pelleting benefits, such as abrasiveness and lubricity, compared to other granulated phosphate feed products. The granulated monocalcium phosphate composition includes one or more additives such as lubricity and abrasivity additives. The lubricity additive can include a sodium additive that lubricates the die during a feed milling or pelleting process. The abrasivity additive can include silica or sand that scours the die during the pelleting process. The increased lubricity and abrasivity attributes of the composition benefits die throughput and efficiency in the pelleting process, without compromising nutritional value in the final feed product.

Abstract: A process for preparing frozen particles having an average diameter of from 1 to 10 mm and comprising from 1 to 50 wt % of a frozen aqueous core and from 50 to 99 wt % of a fat-based shell is provided, the process comprising: providing a dispensing device having an inner nozzle and an outer nozzle which surrounds the inner nozzle; supplying an aqueous mix to the inner nozzle and a fat-based mix to the outer nozzle, thereby forming particles with a water-continuous core and a fat-continuous shell, and then dropping the particles into a refrigerant.